Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: XTX101 ×

XTX101

This drug is selected. Its supporting articles are shown below.

Articles mentioning XTX101

2 articles · page 1 of 1

1315 Plasma tumor mutational burden (pTMB) enriched for response to vilastobart in combination with atezolizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

jitc · abstract · 2025-11-07 · 1 matching annotations

92.6%

vilastobart atezolizumab pembrolizumab

…rable (figure 2). Consistent with the tumor-activated design of vilastobart, treatment was generally well-tolerated: overall (n=44), 11 pat…

541 ctDNA as a potential surrogate biomarker for response to combination vilastobart and atezolizumab in heavily pretreated microsatellite stable (MSS) metastatic colorectal cancer (mCRC) (NCT04896697)

jitc · abstract · 2025-11-04 · 1 matching annotations

94.3%

atezolizumab vilastobart XTX101 MSS mCRC Advarra Institutional Review Board MSS CRC

…c-enhanced anti-CTLA-4 monoclonal antibody, in combination with atezolizumab in patients with advanced solid tumors and in MSS CRC. Journal …